You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Fluoropyrimidine

Showing 1 - 25 of 407
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Cancer Trial in Ann Arbor (DPYD or UGT1A1 variants)

Not yet recruiting
  • Cancer
  • DPYD or UGT1A1 variants
  • Ann Arbor, Michigan
    University of Michigan Rogel Cancer Center
Dec 20, 2022

Colorectal Cancer Stage IV Trial in Sao Paulo (mFOLFIRINOX)

Recruiting
  • Colorectal Cancer Stage IV
  • Sao Paulo, SP, Brazil
    ICESP
Apr 28, 2022

Metastatic Colorectal Cancer Trial in Dijon (Fluoropyrimidine, Bevacizumab)

Recruiting
  • Metastatic Colorectal Cancer
  • Dijon, France
    Chu Dijon Bourgogne
Oct 21, 2021

Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma Trial (pembrolizumab, paclitaxel)

Completed
Has Results
  • Gastric Adenocarcinoma
  • Gastroesophageal Junction Adenocarcinoma
  • (no location specified)
May 12, 2022

Gut Microbiome in Colorectal Cancer

Completed
  • Gastrointestinal Microbiome
  • Neoplasm, Colorectal
    • San Francisco, California
      University of California, San Francisco
    Sep 29, 2022

    Colorectal Cancer, Colon Cancer, Rectal Cancer Trial in Cleveland (CB-839, Capecitabine)

    Active, not recruiting
    • Colorectal Cancer
    • +3 more
    • Cleveland, Ohio
    • +1 more
    Jan 14, 2022

    Metastatic Colorectal Cancer Trial (trifluridine/tipiracil + XB2001, trifluridine/tipiracil + )

    Not yet recruiting
    • Metastatic Colorectal Cancer
    • trifluridine/tipiracil + XB2001
    • trifluridine/tipiracil + placebo
    • (no location specified)
    Jan 15, 2022

    Ras-mutated Metastatic Colorectal Cancer Trial in Napoli (Bevacizumab, mFOLFOX6 regimen, mOXXEL regimen)

    Recruiting
    • Ras-mutated Metastatic Colorectal Cancer
    • Napoli, Campania, Italy
      Istituto Tumori di Napoli - Fondazione G. Pascale
    Sep 1, 2021

    Esophageal Tumor Metastatic, Esophageal Cancer Stage IVb Trial in Beijing (drug, biological, radiation)

    Recruiting
    • Esophageal Neoplasm Metastatic
    • Esophageal Cancer Stage IVb
    • TP (Paclitaxel with cisplatin or carboplatin) or PF (Fluoropyrimidine with cisplatin or carboplatin) regimen depended on investigator's choice.
    • +3 more
    • Beijing, Beijing, China
      Cancer hospital, CAMS
    Oct 19, 2023

    Fluoropyrimidine Tailored-dose Based on Uracil Concentration in

    Completed
    • Digestive Carcinoma
    • Fluoropyrimidine treatment (5-FU or capecitabine) and dosage
    • +2 more
    • Lyon, France
    • +2 more
    Jun 2, 2021

    Esophageal Squamous Cell Carcinoma Trial in Norway, Sweden (radiation, drug, procedure)

    Recruiting
    • Esophageal Squamous Cell Carcinoma
    • Neoadjuvant radiotherapy (arm A)
    • +5 more
    • Oslo, Norway
    • +8 more
    Mar 29, 2022

    Gastric Adenocarcinoma, GastroEsophageal Cancer Trial in Orange, Sacramento (TAS-102, Irinotecan)

    Active, not recruiting
    • Gastric Adenocarcinoma
    • GastroEsophageal Cancer
    • Orange, California
    • +1 more
    Apr 4, 2022

    Tumors Trial in Worldwide (5-FU, Docetaxel, Enzalutamide)

    Completed
    • Neoplasms
    • San Francisco, California
    • +10 more
    Jan 6, 2022

    Triple Negative Breast Cancer, Breast Cancer Trial in Stanford (Capecitabine)

    Recruiting
    • Triple Negative Breast Cancer
    • Breast Cancer
    • Stanford, California
      Stanford University
    Jan 7, 2022

    Advanced Gastric and Gastro-esophageal Junction Adenocarcinoma Trial in Beijing (sintilimab, nab-paclitaxel)

    Recruiting
    • Advanced Gastric and Gastro-esophageal Junction Adenocarcinoma
    • Beijing, China
      Chinese Academy of Medical Sciences
    Mar 9, 2022

    Rectal Adenocarcinoma Trial in Chapel Hill (other, radiation, drug)

    Withdrawn
    • Rectal Adenocarcinoma
    • Chemoradiation
    • +4 more
    • Chapel Hill, North Carolina
      Lineberger Comprehensive Cancer Center at University of North Ca
    Nov 2, 2021

    Metastatic Colorectal Cancer (mCRC) Trial in Nanjing (HLX04 100 mg in 4 ml Injection, Avastin 100 mg in 4 ml Injection)

    Active, not recruiting
    • Metastatic Colorectal Cancer (mCRC)
    • HLX04 100 mg in 4 ml Injection
    • Avastin 100 mg in 4 ml Injection
    • Nanjing, Jiangsu, China
      Nanjing Bayi Hospital Ethics Committee
    May 6, 2022

    Colorectal Cancer Trial in Saint-herblain (Oxaliplatin, Folinic Acid, 5-fluoro-uracil)

    Completed
    • Colorectal Cancer
    • Saint-herblain, France
      Centre rené Gauducheau
    Jan 7, 2022

    Cholangiocarcinoma Trial in Hangzhou (radiofrequency ablation, Chemotherapy drug)

    Recruiting
    • Cholangiocarcinoma
    • radiofrequency ablation
    • Chemotherapy drug
    • Hangzhou, Zhejiang, China
      Hangzhou First People's Hospital
    Aug 25, 2021

    Oncology Trial in Rouen (Bevacizumab in combination with chemo based on fluoropyrimidine IV)

    Unknown status
    • Oncology
    • Bevacizumab in combination with chemotherapy based on fluoropyrimidine IV
    • Rouen, France
      CHU de ROUEN
    Mar 23, 2021

    Advanced Esophageal Adenocarcinoma, Advanced Gastric Adenocarcinoma, Advanced Gastroesophageal Junction Adenocarcinoma Trial

    Not yet recruiting
    • Advanced Esophageal Adenocarcinoma
    • +14 more
    • (no location specified)
    Jan 3, 2023

    Gastric Tumors, Gastroesophageal Junction Adenocarcinoma Trial in Worldwide (Pembrolizumab, Paclitaxel)

    Terminated
    • Gastric Neoplasms
    • Gastroesophageal Junction Adenocarcinoma
    • Beijing, Beijing, China
    • +35 more
    Apr 1, 2022

    Metastatic Colorectal Cancer Trial in France, Martinique (FOLFOX + panitumumab)

    Recruiting
    • Metastatic Colorectal Cancer
    • FOLFOX + panitumumab
    • Sainte Colombe, Lyon, France
    • +45 more
    Mar 23, 2022

    Gastric Cancer Trial in Worldwide (5-Fluorouracil, Ipatasertib, Leucovorin)

    Completed
    Has Results
    • Gastric Cancer
    • Los Angeles, California
    • +33 more
    Feb 18, 2022

    Locally Advanced Rectal Cancer Trial in Seoul (Arm A : standard neoadjuvant chemoradiotherapy group, Arm B : adjuvant FOLFOX

    Active, not recruiting
    • Locally Advanced Rectal Cancer
    • Arm A : standard neoadjuvant chemoradiotherapy group
    • Arm B : adjuvant FOLFOX group
    • Seoul, Korea, Republic of
      Severance Hospital
    Apr 21, 2021